In control

Trio dominate insulin market

99%

Insulin market share, by value, of Eli Lilly, Novo Nordisk and Sanofi

83%

Market share of the three manufacturers in low and middle-income countries

30m

Number of people for whom Eli Lilly plans to improve healthcare access each year in “resourcelimited settings” by 2030